Where does Marijn Dekkers work?

Marijn Dekkers is Chairman at Novalis LifeSciences and Board director at Flywheel Exchange, Inc. and Board director at Vizgen and Board director at Animol.

What boards does Marijn Dekkers sit on?

Marijn Dekkers holds tracked board seats at Agbiome, Animol, Enko Chem, Flywheel Exchange, Inc., Quanterix, Vizgen.

Marijn Dekkers

Investor

Chairman at Novalis LifeSciences · Board director at Flywheel Exchange, Inc. · Board director at Vizgen · Board director at Animol

About

Founder and Chairman of Novalis Capital Partners (2017) and board member of several portfolio companies. Formerly CEO of Bayer AG and Thermo Fisher Scientific, and Chairman of Unilever; holds a PhD in Chemical Engineering.

Contact· self-published, not guessed

m•••@novalislifesciences.comreveal

Likely email· guessed from name + firm domain, not firm-published

m•••@novalislifesciences.comreveal100% confident

Board director at Flywheel Exchange, Inc.

Intro paths

→

In turn, Marijn can intro founders to Flywheel Exchange, Inc.'s investors below.

Flywheel Exchange, Inc.'s investors · 10

8VCAustin · $100K – $50M checks · since 2023 BeringeaLondon · $3M – $10M checks Great North VenturesMaple Grove Intuitive VenturesSunnyvale iSelect FundSt. Louis · $250K – $2M checks LightbankChicago · $500K – $5M checks National Institutes of Health (NIH)Novalis LifeSciencesPortsmouth · since 2025 NVenturesSanta Clara NVIDIASanta Clara

Co-founders at Flywheel Exchange, Inc.

Brian WandellCo-founder

Gunnar SchaeferCo-founder

Board director at Vizgen

Intro paths

→

In turn, Marijn can intro founders to Vizgen's investors below.

Vizgen's investors · 4

ARCH Venture PartnersChicago · $50K – $250M checks · since 2026 M VenturesLos Angeles · $10.8M checks · since 2026 Northpond VenturesBethesda · $100K – $5M checks · since 2026 Novalis LifeSciencesPortsmouth · since 2021

Co-founders at Vizgen

George EmanuelScientific Cofounder, VP & Portfolio Owner, Instruments

Jiang HeScientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs

Board director at Animol

Intro paths

→

In turn, Marijn can intro founders to Animol's investors below.

Animol's investors · 3

Anterra CapitalAmsterdam · $20M checks DYDX CapitalRedwood City Novalis LifeSciencesPortsmouth · since 2022

Co-founders at Animol

Andrew CalabreseScientific Co-Founder

Philip AustinCo-founder (Managing Partner, Anterra Capital)

Deals · 5

Flywheel Exchange, Inc.Board seat

via Novalis LifeSciences · filed Dec 2025 · $27.4M raise

Enko ChemBoard seat

via Novalis LifeSciences · filed Dec 2022 · $80M raise

AgbiomeBoard seat

via Novalis LifeSciences · filed Feb 2022 · $117.2M raise

VizgenBoard seat

via Novalis LifeSciences · filed Apr 2021 · $37M raise

QuanterixBoard seat

via Novalis LifeSciences · filed Jul 2019 · $6.5M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Animol

Per SEC Form D filings.

Colleagues at Novalis LifeSciences

Christel Morley

Business Operations Manager at Novalis LifeSciences

Constantine G. (Dino) Pantelis

COO at Novalis LifeSciences

Devin Leake

Managing Director at Novalis LifeSciences

Dino Pantelis

COO at Novalis LifeSciences

Greg Herrema

Senior Advisor at Novalis LifeSciences

Michael Alter

Senior Analyst at Novalis LifeSciences

Michael McGuire

Accounting Manager at Novalis LifeSciences

Paul Meister

Partner at Novalis LifeSciences

Frequently asked questions

Who is Marijn Dekkers?: Founder and Chairman of Novalis Capital Partners (2017) and board member of several portfolio companies. Formerly CEO of Bayer AG and Thermo Fisher Scientific, and Chairman of Unilever; holds a PhD in Chemical Engineering.
Where does Marijn Dekkers work?: Marijn Dekkers is Chairman at Novalis LifeSciences and Board director at Flywheel Exchange, Inc. and Board director at Vizgen and Board director at Animol.
What boards does Marijn Dekkers sit on?: Marijn Dekkers holds tracked board seats at Agbiome, Animol, Enko Chem, Flywheel Exchange, Inc., Quanterix, Vizgen.